1142 results found | searching for "pharma"

• 
• https://www.ruipugroup.com/application-characteristics-of-ferrous-gluconate/ Ferrous gluconate is compatible with a wide range of excipients, fillers, and binders commonly used in the formulation of tablets, capsules, and other pharmaceutical dosage forms. [more]

  by wen412710,  Chemistry 

  0 reply
• 
• Patient Recruitment Services and Patient Retention Services market Size, Share, Trends by 2035 The recruitment of suitable clinical trial participants is often fraught with several challenges, including scientific and operational complexity, insufficient resources and expertise, issues related to data handling and increasingly stringent regulatory guidelines. As a result, outsourcing has become a popular operating model in this domain, as it enables reduction in costs, optimization of timelines and launch of respective offerings, as per planned timelines. In fact, several patient recruitment firms have begun adopting and implementing modern technical strategies, such as social media platforms, mobile applications, Electronic Health Records (EHRs) and Real-World Evidence (RWE) for patient enrolment. The USD 26.2 billion (by 2035) financial opportunity within the patient recruitment and retention services market has been analyzed across the following segments:  Patient Recruitment Step  Pre-screening  Screening  Trial Phase  Phase I  Phase II  Phase III  Phase IV  Therapeutic Area  Cardiovascular Disorders  Oncological Disorders  Infectious Diseases  CNS Disorders  Respiratory Disorders  Hematological Disorders  Dermatological Disorders  Ophthalmic Disorders  Others  Key Geographical Regions  North America  Europe  Asia Pacific  Latin America  Middle East and North Africa  Rest of the World The Patient Recruitment Services and Patient Retention Services Market (3rd Edition), 2022-2035 report features the following companies, which we identified to be key players in this domain:  BBK Worldwide  Continuum Clinical  IQVIA  United BioSource (UBC)  WCG ThreeWire  Clariness  Fidelis Research  Ignite Data  Innovative Trials  Orphan Reach  3H Medi Solution  Buzzreach  Current Medical Information Center (CMIC)  nRollmed  Trialfacts Table of Contents 1. Preface 2. Executive Summary 3. Introduction 4. Patient Outreach Methods 5. Market Landscape 6. Patient Retention and Patient Recruitment Companies Competitiveness Analysis 7. Company Profiles: Patient Recruitment and Patient Retention Services Providers in North America 8. Company Profiles: Patient Recruitment and Retention Services Providers in Europe 9. Company Profiles: Patient Recruitment and Retention Services Providers in Asia-Pacific and Rest of The World 10. Partnerships and Collaborations 11. Recent Trends in Patient Recruitment and Retention 12. Future Growth Opportunities in Patient Recruitment 13. Case Study: Regulatory Landscape of Patient Recruitment 14. Patient Recruitment in Trials Focused on Personalized Medicines and Rare Diseases 15. Analysis of Demand for Clinical Trial Participants 16. Market Sizing and Opportunity Analysis 17. Concluding Remarks 18. Executive Insights 19. Appendix 1: Tabulated Data 21. Appendix 2: List of Companies and Organizations To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html News article Biopharmaceutical Filtration Market Learn from experts: do you know about these emerging industry trends? mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends Exploring How Artificial Intelligence Is Transforming Digital Pathology About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Learn more about Roots Analysis consulting services: Roots Analysis Consulting - the preferred research partner for global firms Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #PatientRecruitmentServicesandPatientRetentionServicesMarket #PatientRecruitmentServicesandPatientRetentionServicesMarketSize #patientrecruitment #clinicaltrialpatientrecruitment #clinicaltrialrecruitment

  by jameshebrew,  Health 

  0 reply
• 
• Aventure Skincare is a division firm of fastest growing Pharma Franchise Company "Elkos Healthcare Pvt. Ltd. ", one of India's most respected dermatology company. https://www.elkosgroup.in/Derma-Medicine-Company.php

  by Elkoshealthcare,  India 

  0 reply
• 
• Clinical Trials Market size was valued at USD 45.7 billion in the year 2022 and is anticipated to grow USD 69.93 Bn by 2029 at CAGR of 6.2% from 2023-2029. Clinical trials are the research studies primarily performed on the humans to get data about safety and efficacy of newer biomedical interventions include novel devices, vaccines, drugs, and treatments. Generally, clinical trials are regulated by the ethics committees and health authorities. On the broad base, clinical trials are carried to determine the overall pharmacokinetic and pharmacodynamic properties of the products.

  by ramkumarss,  Health 

  0 reply
• 
• Neurovascular Devices/Interventional Neurology Market Research Report | Size & Forecast dailygram The factors driving growth of the Neurovascular Devices/Interventional Neurology Market includes Increasing prevalence of neurovascular disorders around the world, expansion of the pharmaceutical industry, growing demand for minimally invasive surgeries, rise in the geriatric population and improvements in the living standards. More Info, Click to Access Complete Report – https://dailygram.com/blog/1226727/neurovascular-devices-interventional-neurology-market-research-report-size-/ [more]

  by arif11,  Business & Finance 

  0 reply
• 
• Neurovascular Devices/Interventional Neurology Market Research Report | Size & Forecast blogspot The factors driving growth of the Neurovascular Devices/Interventional Neurology Market includes Increasing prevalence of neurovascular disorders around the world, expansion of the pharmaceutical industry, growing demand for minimally invasive surgeries, rise in the geriatric population and improvements in the living standards. More Info, Click to Access Complete Report – https://arife25.blogspot.com/2023/06/neurovascular-devicesinterventional.html [more]

  by arif11,  Business & Finance 

  0 reply
• 
• Latest news on Bacteriophage therapy market Research Report by 2035 Bacteriophage Therapy is an attractive approach to tackle the escalating resistance against antibiotics; over the years, this upcoming class of target specific therapeutic agents has generated significant enthusiasm within the medical science community Roots Analysis has announced the addition of “Bacteriophage Therapeutics Market, 2022-2035” report to its list of offerings. The report features an extensive study on the current market landscape, offering an informed opinion on the likely evolution and future opportunities associated with the bacteriophage therapeutics market. The study underlines an in-depth analysis, highlighting the key drivers and the market trends related to this evolving segment of the pharmaceutical industry. Amongst other elements, the report includes:  A summary of the key insights from the bacteriophage therapeutics market. It offers a high-level view on the current state of the market and its likely evolution in the mid to long term.  A general overview of the historical evolution of bacteriophages and their biology. It also includes a detailed discussion on applications of bacteriophage therapy. The chapter concludes with a discussion on the various advantages and limitations associated with the bacterio-phage therapy.  A detailed overview of the overall market landscape of bacteriophage therapeutics, including information on their current status of development, key therapeutic areas, type of bacterial strain, target disease indication, type of therapy, route of administration, and information on bacteriophage related technologies.  An overview of the current status of the market with respect to the players engaged in the manufacturing of bacteriophage therapeutics, featuring information on the year of establishment, company size, location of headquarters, and leading developers.  Elaborate profiles of the prominent players engaged in the development of bacteriophage therapeutics.  An in-depth analysis of completed, ongoing and planned clinical studies, based on several relevant parameters, such as trial registration year, trial phase, enrolled patient population, study design, type of sponsor / collaborator, most active players, registered trials, and geographical region.  An in-depth analysis of the various patents that have been filed / granted related to bacteriophage therapeutics. It includes information on key parameters. It also highlights the leading industry and non-industry players and individual assignees.  An in-depth analysis of various publications for bacteriophage therapeutics, based on several relevant parameters, such as year of publication, type of article, popular keywords, most popular publishers, key journals. It also highlights benchmarking of the publications to develop more insightful opinions on the recent trends related to research and development in this area.  A detailed study of the various grants that have been awarded to research institutes engaged in projects related to bacteriophage therapeutics, since 2017, highlighting various important parameters.  An in-depth analysis of the investments made, including grants, venture capital financing, initial public offering, secondary offering, private placement, equity and debt funding, at various stages of development, in companies that are focused on developing bacteriophage therapeutics.  A detailed study of the recent collaborations and partnership established in this domain since 2017, including the details of deals that were / are focused on the development of bacteriophage therapeutics.  An analysis of the various start-ups engaged in the development of bacteriophage therapeutics, based on relevant parameters, such as pipeline strength, pipeline maturity, indication diversity, number of patents, financial support and partnership activity The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Gastrointestinal Infections  Bacterial Dysentery  Multiple Infections  Other Infections  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa Key Companies covered in the report  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Bispecific Antibodies Market Novel Cell Cytometers: Need of the Hour Bispecific Antibodies Market Roots Analysis Consulting - the preferred research partner for global firms About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #BacteriophagetherapymarketGrowth #BacteriophagetherapymarketTrends #bacteriophagetherapeutics #phagetherapy #bacteriophagemarket

  by jameshebrew,  Health 

  0 reply
• 
• Technological Advancements Propel Veterinary API Market to New Heights https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.html The veterinary API industry is poised for significant growth in the near future. As pet ownership continues to rise and people's awareness of animal health and welfare deepens, the demand for veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) is expected to skyrocket. With advancements in technology and research, the industry is likely to witness the development of innovative APIs that are more efficient and tailored to specific animal species, ensuring optimal therapeutic outcomes. Additionally, there is a growing focus on the use of natural and herbal APIs, reflecting the increasing preference for holistic and alternative veterinary treatments. Furthermore, the integration of digital solutions, such as telemedicine and remote monitoring, will revolutionize veterinary care, enabling accurate diagnosis, personalized treatment plans, and enhanced overall healthcare for animals. The veterinary API industry, driven by these transformative trends, is set to make significant strides in improving animal health and well-being in the near future. Veterinary API Market in terms of revenue was estimated to be worth $5.2 billion in 2023 and is poised to reach $7.1 billion by 2028, growing at a CAGR of 6.5% from 2023 to 2028 according to a new report by MarketsandMarkets™. The market for veterinary API is expanding because of factors like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products. This is also going to attract international investors to that region. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91801752 Browse in-depth TOC on "Veterinary API Market" 150 – Tables | 60 – Figures | 350 - Pages In this report, the Veterinary API Market is segmented based on API Type, Synthesis Type, Route of Administration, Animal Type, and region. Veterinary API - Key Market Players: The prominent players in the global Veterinary API Market are Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insulnsud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China) Report Metric Details Market Size Available for Years 2021–2028 Base Year Considered 2022 Forecast Period 2023–2028 Forecast Unit Value (USD Million/Billion) Segments Covered API type, Synthesis Type, Route of Administration, Animal Type, and Region Countries Covered • North America o US o Canada • Europe o Germany o UK o France o Spain o Italy o Rest of Europe • Asia Pacific o China o Australia o Japan o India o South Korea o Rest of APAC • Latin America o Brazil o Rest of LATAM • Middle East and Africa o Turkey o Rest of MEA Oral segment in Route of administration was dominated by the highest share in Veterinary API Market The Veterinary API Market is divided into four types based on Route of administration such as Oral, Injectable, Topical, and Others. The Oral segment accounted for the highest share of the global Veterinary API Market in 2022. Oral administration of veterinary drugs is relatively easy and can be performed by the pet owner or veterinary professional. It typically involves the use of tablets, capsules, liquids, or treats that can be readily consumed by animals. The oral route is suitable for a wide range of veterinary drugs, including antibiotics, antiparasitics, analgesics, and medications for chronic conditions. Companion animal segment was dominated by the highest share in Veterinary API Market The Veterinary API Market is segmented based on animal type into two categories: companion animals and livestock animals. In 2022, companion animals dominated the Veterinary API Market, holding the largest market share. This can be attributed to the increasing focus on preventive healthcare for companion animals and the rise in pet ownership, among other factors. These factors have contributed significantly to the significant proportion of the market occupied by companion animals. North America accounted for the largest share of the Veterinary API Market in 2022 The Veterinary API Market is categorized into five geographical regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America emerged as the dominant region, capturing the largest market share for Veterinary APIs globally. The growth of the North America market is expected to be driven by factors such as increased investments in research and development for veterinary API manufacturing and government backing for the establishment of API manufacturing facilities. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91801752 Veterinary API Market Dynamics: Drivers: • Rising incidence of transboundary & zoonotic diseases • Increasing animal population and pet ownership • Increasing disease control & disease prevention measures • Growing demand for animal protein Restraints: • High costs of veterinary diagnostic and treatment • Growing concerns about antibiotic resistance Opportunities: • Rising awareness about animal health and welfare • Untapped emerging economies Challenges: • Growing concerns about antibiotic resistance • Challenges In Large Molecule Api Synthesis Recent Developments: • In 2021, Sequent Scientific Ltd. (India) received WHO–GENEVA approval for API Praziquantel (Anthelmintic) under the prequalification program. • In 2020, Sequent Scientific Ltd. Opened a state-of-the-art animal health R&D center in Mumbai, India. Primary Research To gather qualitative and quantitative data for this study, a variety of sources from the supply and demand sides were interviewed during the main research phase. CEOs, vice presidents, marketing and sales directors, business development managers, technology, and innovation directors of Veterinary API Market manufacturing businesses, key opinion leaders, suppliers, and distributors are the main sources on the supply side. Secondary Research There were several secondary sources used in this study, including directories, databases like Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, corporate house documents, investor presentations, and firm SEC filings. To find and gather data for the detailed, technical, market-focused, and commercial analysis of the Veterinary API Market, secondary research was carried out. Relevant information on major companies, market classification and segmentation according to industry trends down to the most basic level, and significant changes regarding market and technological views were also obtained. Additionally, utilizing secondary research, a database of the important industry executives was created. Objectives of the Study: • To define, describe, segment, and forecast the Veterinary API Market based on API type, Synthesis Type, Route of Administration, Animal Type, and region. • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges). • To assess the Veterinary API Market regarding Porter's five forces analysis, regulatory landscape, value chain, supply chain, ecosystem analysis, patent analysis, and the impact of the economic recession. • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market. • To forecast the size of the Veterinary API Market in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape. • To profile the key players in the Veterinary API Market and comprehensively analyze their core competencies. • To track and analyze competitive developments such as product launches and approvals, acquisitions, expansions, partnerships, and agreements in the Veterinary API Market. Research Insight: https://www.marketsandmarkets.com/ResearchInsight/veterinary-api-market.asp Content Source: https://www.marketsandmarkets.com/PressReleases/veterinary-api.asp

  by Healthcare_medical,  Health 

  0 reply
• 
• https://www.precisionbusinessinsights.com/market-reports/microbial-biopharmaceuticals-market The global microbial biopharmaceuticals market size was valued at USD 308 billion in 2022 and is poised to grow at a significant CAGR of 14.7% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region.

  by vamshee,  Health 

  0 reply
• 
• https://www.ruipugroup.com/zinc-gluconate-play-in-the-pharmaceutical-industry/ Zinc gluconate is used in some topical formulations and wound care products due to its potential benefits for skin health and wound healing. [more]

  by wen412710,  Chemistry 

  0 reply